These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 7994786)

  • 1. Comparison of the prophylactic usefulness of epirubicin and doxorubicin in the treatment of superficial bladder cancer by intravesical instillation: a multicenter randomized trial. Kobe University Urological Oncology Group.
    Eto H; Oka Y; Ueno K; Nakamura I; Yoshimura K; Arakawa S; Kamidono S; Obe S; Ogawa T; Hamami G
    Cancer Chemother Pharmacol; 1994; 35 Suppl():S46-51. PubMed ID: 7994786
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A phase II study of prophylactic intravesical chemotherapy with 4'-epirubicin in recurrent superficial bladder cancer: comparison of 4'-epirubicin and adriamycin.
    Shuin T; Kubota Y; Noguchi S; Hosaka M; Miura T; Kondo I; Fukushima S; Ishizuka E; Furuhata A; Moriyama M
    Cancer Chemother Pharmacol; 1994; 35 Suppl():S52-6. PubMed ID: 7994787
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prophylactic chemotherapy with anthracyclines (adriamycin, epirubicin, and pirarubicin) for primary superficial bladder cancer. The Hokkaido University Bladder Cancer Collaborative Group.
    Shinohara N; Nonomura K; Tanaka M; Nagamori S; Takakura F; Seki T; Koyanagi T; Togashi M; Maru A
    Cancer Chemother Pharmacol; 1994; 35 Suppl():S41-5. PubMed ID: 7994785
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomized trial of early intravesical instillation of epirubicin in superficial bladder cancer. The Nagoya University Urological Oncology Group.
    Okamura K; Murase T; Obata K; Ohshima S; Ono Y; Sakata T; Hasegawa Y; Shimoji T; Miyake K
    Cancer Chemother Pharmacol; 1994; 35 Suppl():S31-5. PubMed ID: 7994783
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intravesical epirubicin versus doxorubicin for superficial bladder tumors (stages pTa and pT1): a randomized prospective study.
    Ali-el-Dein B; el-Baz M; Aly AN; Shamaa S; Ashamallah A
    J Urol; 1997 Jul; 158(1):68-73; discussion 73-4. PubMed ID: 9186325
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Intravesical instillation of doxorubicin or epirubicin for chemoprophylaxis of superficial bladder cancer--the fifth study of the Japanese Urological Cancer Research Group for Adriamycin/Farumorubicin].
    Hinotsu S; Akaza H; Isaka S; Kagawa S; Koiso K; Kotake T; Machida T; Matsumura Y; Niijima T; Obata K; Ohashi Y; Ohe H; Shimazaki J; Tashiro K;
    Gan To Kagaku Ryoho; 2002 Jan; 29(1):73-80. PubMed ID: 11816482
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomized controlled trial of short-term versus long-term prophylactic intravesical instillation chemotherapy for recurrence after transurethral resection of Ta/T1 transitional cell carcinoma of the bladder.
    Koga H; Kuroiwa K; Yamaguchi A; Osada Y; Tsuneyoshi M; Naito S
    J Urol; 2004 Jan; 171(1):153-7. PubMed ID: 14665865
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prophylactic intravesical instillation chemotherapy against recurrence after a transurethral resection of superficial bladder cancer: a randomized controlled trial of doxorubicin plus verapamil versus doxorubicin alone. The Kyushu University Urological Oncology Group.
    Naito S; Kotoh S; Omoto T; Osada Y; Sagiyama K; Iguchi A; Ariyoshi A; Hiratsuka Y; Kumazawa J
    Cancer Chemother Pharmacol; 1998; 42(5):367-72. PubMed ID: 9771950
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adjuvant chemotherapy with early intravesical instillation of adriamycin and long-term oral administration of 5-fluorouracil in superficial bladder cancer. The Kyushu University Urological Oncology Group.
    Ueda T; Naito S; Iguchi A; Sagiyama K; Osada Y; Ariyoshi A; Omoto T; Kumazawa J
    Cancer Chemother Pharmacol; 1992; 30 Suppl():S31-6. PubMed ID: 1394813
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A phase II study of prophylactic intravesical chemotherapy with epirubicin in the treatment of superficial bladder cancer. Tokyo Women's Medical College Bladder Cancer Collaborating Group.
    Ryoji O; Toma H; Nakazawa H; Goya N; Okumura T; Sonoda T; Kihara T; Tanabe K; Onizuka S; Tomoe H
    Cancer Chemother Pharmacol; 1994; 35 Suppl():S60-4. PubMed ID: 7994789
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase II study of intravesical chemoprophylaxis of epirubicin after transurethral resection of bladder tumors. Tottori University Oncology Group.
    Watanabe N; Miyagawa I; Higasibori Y; Nakahara T; Sumi F; Ishida G; Abe B; Inoue A; Hanamoto N
    Cancer Chemother Pharmacol; 1994; 35 Suppl():S57-9. PubMed ID: 7994788
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prophylactic intravesical chemotherapy with adriamycin plus verapamil for primary superficial bladder cancer: preliminary results. The Kyushu University Urological Oncology Group.
    Naito S; Ueda T; Kotoh S; Iguchi A; Sagiyama K; Hiratsuka Y; Osada Y; Ariyoshi A; Omoto T; Kumazawa J
    Cancer Chemother Pharmacol; 1994; 35 Suppl():S76-80. PubMed ID: 7994792
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early and large-dose intravesical instillation of epirubicin to prevent superficial bladder carcinoma recurrence after transurethral resection.
    Mitsumori K; Tsuchiya N; Habuchi T; Li Z; Akao T; Ohyama C; Sato K; Kato T
    BJU Int; 2004 Aug; 94(3):317-21. PubMed ID: 15291859
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Intravesical instillation of epirubicin in the prophylactic treatment of recurrent superficial bladder cancer].
    Kobayashi M; Sugaya Y; Yuzawa M; Morita T; Kobayashi Y; Tokue A
    Hinyokika Kiyo; 1998 Dec; 44(12):861-4. PubMed ID: 10028430
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of intravesical chemoimmunotherapy with epirubicin and bacillus Calmette-Guérin for prophylaxis of recurrence of superficial bladder cancer: a preliminary report.
    Uekado Y; Hirano A; Shinka T; Ohkawa T
    Cancer Chemother Pharmacol; 1994; 35 Suppl():S65-8. PubMed ID: 7994790
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current views on intravesical treatment and chemoprophylaxis of superficial bladder cancer. The present role of epirubicin and doxorubicin.
    Pavone-Macaluso M; Tripi M; Ingargiola GB; Corselli G; Pavone C; Serretta V
    J Chemother; 1993 Jun; 5(3):207-11. PubMed ID: 8371131
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Intravesical instillation of epirubicin hydrochloride in superficial bladder tumor--prophylactic and therapeutic instillation for carcinoma in situ].
    Shichiri Y; Kanba T; Yoshida S; Arai Y
    Hinyokika Kiyo; 1995 May; 41(5):359-64. PubMed ID: 7598036
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prospective randomized study of prophylaxis of superficial bladder cancer with epirubicin: the role of a central pathology laboratory. Nara Uro-oncology Research Group. (NUORG).
    Hirao Y; Ozono S; Momose H; Okajima E; Hiramatsu T; Yoshida K; Fukushima S; Ohashi Y
    Cancer Chemother Pharmacol; 1994; 35 Suppl():S36-40. PubMed ID: 7994784
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The 4th study of prophylactic intravesical chemotherapy with adriamycin in the treatment of superficial bladder cancer: the experience of the Japanese Urological Cancer Research Group for Adriamycin.
    Matsumura Y; Akaza H; Isaka S; Kagawa S; Koiso K; Kotake T; Machida T; Niijima T; Obata K; Ohashi Y
    Cancer Chemother Pharmacol; 1992; 30 Suppl():S10-4. PubMed ID: 1394809
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomized study of short-versus long-term intravesical epirubicin instillation for superficial bladder cancer. Nagoya University Urological Oncology Group.
    Okamura K; Kinukawa T; Tsumura Y; Otani T; Itoh H; Kobayashi H; Matsuura O; Kobayashi M; Fukatsu T; Ohshima S
    Eur Urol; 1998; 33(3):285-8; discussion 289. PubMed ID: 9555553
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.